Kari M Morrissey

3PUBLICATIONS
3CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 16, 2020
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma.

Patrick Y Wen, Timothy F Cloughesy, Alan G Olivero

|Sep 23, 2019
Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting.

Kari M Morrissey, Mathilde Marchand, Hina Patel

|Apr 12, 2019
Investigation of the absolute bioavailability and human mass balance of navoximod, a novel IDO1 inhibitor.

Shuguang Ma, Julia Suchomel, Evelyn Yanez

Pageof 1